Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer Journal Article

  

Authors:	Arbour, K. C.; Riely, G. J.
Article Title:	Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer
Keywords:	mitogen activated protein kinase; treatment outcome; mutation; bevacizumab; erlotinib; cancer combination chemotherapy; drug efficacy; monotherapy; cancer immunotherapy; progression free survival; epidermal growth factor receptor; editorial; drug resistance; phosphatidylinositol 3 kinase; drug receptor binding; drug response; pazopanib; binding site; maximum tolerated dose; b raf kinase; disease exacerbation; drug delivery system; epidermal growth factor receptor kinase inhibitor; programmed death 1 receptor; non small cell lung cancer; molecularly targeted therapy; afatinib; human; priority journal; osimertinib
Journal Title:	Cancer
Volume:	124
Issue:	11
ISSN:	0008-543X
Publisher:	Wiley Blackwell
Date Published:	2018-06-01
Start Page:	2272
End Page:	2275
Language:	English
DOI:	10.1002/cncr.31289
PROVIDER:	scopus
PUBMED:	29645085
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045245270&doi=10.1002%2fcncr.31289&partnerID=40&md5=17c9bc94ff11a3bcfc909574904cadf9
Notes:	Editorial -- Export Date: 2 July 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/126061